What is dr paul cox's role and title at neurocept as of 2025?
This fact-check may be outdated. Consider refreshing it to get the most current information.
Executive summary
Available sources from 2021–2025 identify Paul Alan Cox as the founder and leader of organizations called the Institute for Ethnomedicine and Brain Chemistry Labs; multiple bios list him as Executive Director or Director of those entities [1] [2] [3]. None of the supplied documents say what his role or title at Neurocept is as of 2025 — available sources do not mention any connection between Paul Cox and Neurocept (not found in current reporting).
1. What the supplied reporting actually says about Paul Alan Cox’s roles
The materials provided consistently describe Paul Alan Cox as the leader of his nonprofit research operations. The Institute for Ethnomedicine and its research arm, Brain Chemistry Labs, are repeatedly associated with Cox — he is listed as Director of the Institute for Ethnomedicine [3] and as Executive Director of Brain Chemistry Labs in multiple places [1] [2]. Journalistic profiles describe him running a small lab in Jackson Hole focused on neurodegenerative disease work through these organizations [4] [5].
2. Evidence that Cox is identified as “Executive Director” or “Director”
A profile page explicitly names him Paul Alan Cox, Ph.D., and ties him to Brain Chemistry Labs and the Institute for Ethnomedicine [1]. A news item announcing a diagnostic test likewise calls him Executive Director of Brain Chemistry Labs [2]. A speaker bureau biography lists him as Director of the Institute for Ethnomedicine and describes ongoing ethnobotanical work on Alzheimer’s and ALS [3]. Those are the job titles shown in the supplied reporting.
3. Where the question about Neurocept runs into missing evidence
The search results you provided include no document that links Paul Alan Cox to Neurocept. None of the bios, news pieces, profiles, or organizational pages mention Neurocept in relation to Cox [5] [1] [4] [2] [3]. Therefore, any statement that Cox holds a title at Neurocept as of 2025 would be unsupported by these sources — available sources do not mention Cox’s role at Neurocept (not found in current reporting).
4. Possible reasons for the gap and how to resolve it
There are three plausible explanations consistent with the supplied material: (a) Cox has no formal role at Neurocept and remains focused on Institute for Ethnomedicine/Brain Chemistry Labs (the profiles emphasize those organizations) [1] [2] [3]; (b) Cox could have taken a role at Neurocept that postdates these documents and therefore is absent from the provided set (not found in current reporting); or (c) a role exists but isn’t documented in the particular sources you supplied (not found in current reporting). To resolve this, consult Neurocept’s 2025 leadership page, SEC/press filings, or contemporary news releases — those sources are not among the documents you gave me.
5. What this says about verifying executive titles in biotech
Executive and advisory titles in small biotech and nonprofit research groups change often and can be claimed in many places (press bios, speaker pages, organizational sites). The supplied evidence shows Cox publicly using leadership titles tied to his own nonprofit work [1] [2] [3]. That track record does not substitute for a direct citation tying him to Neurocept; responsible reporting requires a primary source from Neurocept or a contemporaneous independent news report.
6. Recommended next steps for confirmation
If you need a definitive 2025 title for Paul Cox at Neurocept, check Neurocept’s official website and press releases, corporate filings or leadership disclosures, recent SEC/clinical-trial registries, and reliable trade press. Those sources were not provided here; the documents you supplied do not mention any Neurocept affiliation (not found in current reporting).